Literature DB >> 8361820

American Academy of Pediatrics Committee on Infectious Diseases: Use of ribavirin in the treatment of respiratory syncytial virus infection.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8361820

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  23 in total

Review 1.  Respiratory syncytial virus infection: clinical presentation and management.

Authors:  J A Patel; K Deka; P L Ogra
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

Review 2.  Ongoing developments in RSV prophylaxis: a clinician's analysis.

Authors:  Fariba Rezaee; Debra T Linfield; Terri J Harford; Giovanni Piedimonte
Journal:  Curr Opin Virol       Date:  2017-05-10       Impact factor: 7.090

3.  Lower airway disease caused by respiratory syncytial virus.

Authors:  R Aggarwal
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

4.  Analysis of antibiotic use and misuse in children hospitalized with RSV infection.

Authors:  L Samson; C Cooke; N Macdonald
Journal:  Paediatr Child Health       Date:  1999-04       Impact factor: 2.253

5.  Qingkailing Injection () for Treatment of Children Pneumonia Induced by Respiratory Syncytial Virus: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Shuai He; Wen-Shi Li; Ya-Jun Luo; Chen-Li Ye; Zhong-Yi Zhang
Journal:  Chin J Integr Med       Date:  2017-08-17       Impact factor: 1.978

6.  Blocking Respiratory Syncytial Virus Entry: A Story with Twists.

Authors:  Marco Weisshaar; Robert Cox; Richard K Plemper
Journal:  DNA Cell Biol       Date:  2015-05-11       Impact factor: 3.311

7.  Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.

Authors:  Robert Jordan; Matt Shao; Richard L Mackman; Michel Perron; Tomas Cihlar; Sandy A Lewis; Eugene J Eisenberg; Anne Carey; Robert G Strickley; Jason W Chien; Mark L Anderson; Heather A McEligot; Nicole E Behrens; Laurel J Gershwin
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

8.  Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice.

Authors:  K Sudo; W Watanabe; K Konno; R Sato; T Kajiyashiki; S Shigeta; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 9.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

10.  Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.

Authors:  Dan Yan; Sujin Lee; Vidhi D Thakkar; Ming Luo; Martin L Moore; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.